Ceftriaxone Sodium/Sulbactam sodium

头孢曲松钠/舒巴坦钠

Report date: 2026/04/21 20:00:18

Base Information

Drug NameCeftriaxone Sodium/Sulbactam sodium
Drug Alias NameCeftriaxone Sodium+Sulbactam sodium头孢曲松钠+舒巴坦钠舒巴坦钠+头孢曲松钠Sulbactam sodium+Ceftriaxone Sodium舒巴坦钠/头孢曲松钠 +[6] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBeta Lactamase inhibitorsCell wall inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsUrinary Tract InfectionsRespiratory Tract InfectionsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2011/01/28
Country/TerritoryMainland China
CombinationsYes Ceftriaxone SodiumSulbactam sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Salubris Pharmaceuticals Co LtdBeijing Hongtaiyang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Sunho Pharmaceutical Co LtdBeijing Sunho Pharmaceutical Co LtdWelman (Xiang Bei) Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Tract InfectionsRespiratory Tract InfectionsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CG01
Related LinksN/A